Drugs / KL16-012
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04239469 Comparator | Jan → Jun 2020 | fibromyalgia | Knop Laboratorios | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KL16-012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04239469 ↗ |